附件 厦门延江新材料股份有限公司 2023年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 编制单位：厦门延江新材料股份有限公司 | | | | | | | | | 单位：人民币万元 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算的会计 | 2022年期初占用资金 | 2022年度占用累计发 | 2022年度占用资 | 2022年度偿还累计 | 2022年期末占用资 占用形成原因 占用性质 | | | | | 司的关联关系 | 科目 | 余额 | 生额（不含利息) | 金的利息(如有) | 发生金额 | 金余额 | | | 控股股东、实际控制人及 | | | | | | | | | | | 其附属企业 | | | | | | | | | | | 小计 | | | | | | | | | | | 前控股股东、实际控制人 | | | | | | | | | | | 及其附属企业 | | | | | | | | | | | 小计 | | | | | ...

二、保荐机构发现公司存在的问题及采取的措施 | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1、信息披露 | 无 | 不适用 | | 2、公司内部制度的建立和执行 | 无 | 不适用 | | 3、"三会"运作 | 无 | 不适用 | | 4、控股股东及实际控制人变动 | 无 | 不适用 | | 5、募集资金存放及使用 | 无 | 不适用 | | 6、关联交易 | 无 | 不适用 | | 7、对外担保 | 无 | 不适用 | | 8、收购、出售资产 | 无 | 不适用 | | 9、其他业务类别重要事项（包括对 外投资、风险投资、委托理财、财 | 无 | 不适用 | | 务资助、套期保值等） | | | | 10、发行人或者聘请的中介机构配 | 无 | 不适用 | | 合保荐工作的情况 | | | | 11、其他（包括经营环境、业务发 | 无 | 不适用 | | 展、财务状况、管理状况、核心技 | | | | 术等方面的重大变化情况） | | | 国泰君安证券股份有限公司 关于厦门延江新材料股份有限公司 2023 年半年度持续督导跟踪报告 | 保荐机构名称：国泰君安证券股 ...

厦门延江新材料股份有限公司 第三届董事会第十九次会议决议的公告 证券代码：300658 证券简称：延江股份 公告编号：2023-048 厦门延江新材料股份有限公司 第三届董事会第十九次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 厦门延江新材料股份有限公司（以下简称"公司"）第三届董事会第十九次会 议于 2023 年 8 月 28 日在公司会议室召开，会议由董事长谢继华召集并主持。本 次会议通知于 2023 年 8 月 18 日以书面和电子邮件等方式送达各位董事。本次会 议应出席董事 9 名，实际出席 9 名。会议采用现场表决与通讯表决相结合的方式 进行。会议的召开符合《中华人民共和国公司法》及公司章程的规定。公司监事 和高管列席了会议。 二、董事会会议审议情况 1、审议通过《关于首次公开发行股票募集资金投资项目结项并将节余募集 资金永久补充流动资金的议案》 经表决，9 票同意，0 票反对，0 票弃权。公司独立董事对上述议案发表了 同意的独立意见。 具体内容详见 2023 年 8月 29 日公司于中国证券监督管理委员会 ...

第三届监事会第十六次会议决议的公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 厦门延江新材料股份有限公司 第三届监事会第十六次会议决议的公告 证券代码：300658 证券简称：延江股份 公告编号：2023-049 厦门延江新材料股份有限公司 二、监事会会议审议情况 经审核，监事会认为：公司董事会编制和审核《2023 年半年度报告及其摘 要》的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完 整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 厦门延江新材料股份有限公司（以下简称"公司"）第三届监事会第十六次会 议于 2023 年 8 月 28 日在公司会议室召开，会议由监事长蔡吉祥召集并主持。本 次会议通知于 2023 年 8 月 18 日以书面和电子邮件等方式送达各位监事。本次会 议应出席监事 3 名，实际出席 3 名。会议采用现场表决的方式进行。会议的召开 符合《中华人民共和国公司法》及公司章程的规定。公司董事和高管列席了会议。 1、审议通过《关于首次公开发行股票募集资金投资项目结项并将节余募集 资金永久补充流动资 ...

关于召开 2023 年第一次临时股东大会通知的公告 厦门延江新材料股份有限公司 关于召开2023年第一次临时股东大会通知的公告 证券代码：300658 证券简称：延江股份 公告编号：2023-054 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 厦门延江新材料股份有限公司（以下简称"公司"）第三届董事会第十九次会 议决定于 2023 年 9 月 15 日（星期五）召开 2023 年第一次临时股东大会。本次 会议采取现场投票与网络投票相结合的方式召开，现将会议有关事项通知如下：： 厦门延江新材料股份有限公司 一、召开会议的基本情况 1、股东大会届次：厦门延江新材料股份有限公司（以下简称"公司"）2023 年第一次临时股东大会 2、股东大会的召集人：公司董事会 3、会议召开的合法、合规性：公司于 2023 年 8 月 28 日召开的第三届董事 会第十九次会议审议通过了《关于召开 2023 年第一次临时股东大会通知的议案》， 本次会议的召集程序符合有关法律、法规和《厦门延江新材料股份有限公司章程》 等有关规定。 4、会议召开时间： （1）现场会议召开时间：2023 ...

根据《证券法》、《深圳证券交易所创业板股票上市规则》、《上市公司自律监 管指引第 2 号——创业板上市公司规范运作》等相关法律、法规和规章制度以及 公司《监事会议事规则》的要求，公司监事会对第三届监事会第十六次会议相关 事项进行了认真审核，现发表审核意见如下： 一、关于首次公开发行股票募集资金投资项目结项并将节余募集资金永久补 充流动资金的专项审核意见 厦门延江新材料股份有限公司 监事会关于第三届监事会第十六次会议相关事项的 专项审核意见 监事会 2023 年 8 月 28 日 经审核，监事会认为：公司董事会编制和审核《2023 年半年度报告及其摘 要》的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完 整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 厦门延江新材料股份有限公司 经审核，监事会认为：公司将首次公开发行股票募集资金投资项目结项并将 节余募集资金永久补充公司流动资金系基于实际情况做出的审慎决策，有利于提 高募集资金使用效率，符合全体股东利益，本次事项审议程序符合《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关法律、 法规及规 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥314,065,647.82, a decrease of 3.28% compared to ¥323,665,417.62 in the same period last year[5] - Net profit attributable to shareholders increased by 11.65% to ¥6,951,161.83 from ¥6,693,933.61 year-on-year[5] - The net profit after deducting non-recurring gains and losses rose by 38.66% to ¥4,041,026.23 compared to ¥3,382,345.01 in the previous year[5] - Basic and diluted earnings per share decreased by 8.06% to ¥0.0251 from ¥0.0294 year-on-year[5] - Net profit for Q1 2023 was CNY 8,489,599.35, representing an increase of 26.5% from CNY 6,708,757.30 in Q1 2022[25] - The company reported a decrease in comprehensive income, totaling CNY -9,653,475.63, compared to CNY 4,950,541.40 in Q1 2022[26] Cash Flow - Cash flow from operating activities saw a significant increase of 1,197.78%, reaching ¥83,479,476.32, up from ¥6,432,502.28 in the same quarter last year[5] - The net cash flow from operating activities reached ¥83,479,476.32, a significant increase of 1197.78% compared to the previous period's ¥6,432,502.28[11] - Cash received from other operating activities amounted to ¥9,833,818.95, reflecting a 227.06% increase from ¥3,006,772.11 in the prior period, primarily due to higher government subsidies and insurance claims[11] - The cash flow from financing activities showed a net outflow of ¥10,762,461.15, a decline of 111.91% compared to a net inflow of ¥90,359,640.55 in the previous period, driven by reduced bank loan withdrawals and increased repayments[11] - The company experienced a net decrease in cash and cash equivalents of -¥30,243,780.13, compared to -¥15,716,714.64 in the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,680,663,791.37, a decrease of 1.03% from ¥2,708,498,958.71 at the end of the previous year[5] - The company’s equity attributable to shareholders decreased by 0.79% to ¥1,369,742,148.03 from ¥1,380,713,515.93 at the end of the previous year[5] - Current assets decreased from CNY 1,221,496,480.71 to CNY 1,172,152,794.24, representing a reduction of about 4.04%[20] - Total liabilities decreased from CNY 1,308,614,954.46 to CNY 1,290,433,262.76, a reduction of about 1.38%[21] Investment Activities - The total cash inflow from investment activities was ¥122,189,360.08, down 53.64% from ¥263,592,855.53, attributed to a decrease in the redemption of financial products[11] - Cash outflow for investment activities totaled ¥220,469,235.20, a decrease of 41.31% from ¥375,646,718.23, due to reduced amounts for financial products and project payments[11] - The net cash flow from investment activities was -¥98,279,875.12, compared to -¥112,053,862.70 in the previous year, indicating a slight improvement[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,306, with no preferred shareholders having restored voting rights[13] - The largest shareholder, Xie Jihua, holds 21.28% of the shares, amounting to 59,019,075 shares, with 25,000,000 shares pledged[13] Foreign Exchange Impact - The company reported a significant foreign exchange impact on cash and cash equivalents, with a loss of ¥4,680,920.18, an increase of 928.79% from the previous loss of ¥454,994.77[11] - The company recorded a foreign exchange gain of CNY 1,214,733.59, compared to a loss of CNY -2,869,800.00 in the same period last year[25] Research and Development - Research and development expenses increased to CNY 9,519,762.95, up 11.4% from CNY 8,543,414.08 in the same quarter last year[23] Other Information - The company recognized government subsidies amounting to ¥1,931,654.64, which are closely related to its normal business operations[9] - The company completed the cancellation of unexercised restricted stocks during the reporting period, totaling 138,206,113 shares[18] - The company plans to continue its market expansion and product development strategies in the upcoming quarters[19] - The first quarter report was not audited[29]

Financial Performance - The company's operating revenue for 2022 was CNY 1,230,401,890, a decrease of 1.95% compared to CNY 1,249,100,590 in 2021[33]. - Net profit attributable to shareholders for 2022 was CNY 29,377,334.4, representing a significant increase of 62.48% from CNY 16,842,500.9 in 2021[33]. - The net cash flow from operating activities for 2022 was CNY 131,739,711.71, an increase of 146.60% compared to CNY 53,421,994.7 in 2021[33]. - Basic earnings per share for 2022 was CNY 0.12, a 50.00% increase from CNY 0.07 in 2021[33]. - Total assets at the end of 2022 reached CNY 2,708,498,958.71, a growth of 25.72% from CNY 2,153,157,800 in 2021[33]. - The net assets attributable to shareholders at the end of 2022 were CNY 1,380,713,515.93, reflecting a 36.53% increase from CNY 1,010,017,450 in 2021[33]. - The company reported a significant increase in non-recurring gains and losses, with a net profit of CNY 5,527,301.75 in 2022 compared to a loss of CNY 8,002,572.58 in 2021, marking an improvement of 181.71%[33]. - The company achieved a net profit of CNY 7,082,853.65 in 2020, which decreased to CNY 4,133,420.45 in 2021, and faced operational losses in 2022 due to rising raw material costs and exchange rate losses[68]. - The company reported a total revenue of 80.92 million in the latest fiscal year, with a significant increase of 5.00% compared to the previous year[142]. Customer Concentration and Market Risks - In 2022, the top five customers contributed sales revenue of 1,005.64 million CNY, accounting for 81.73% of total revenue, indicating a high customer concentration risk[7]. - The company reported a significant reliance on a few major clients, with the top five clients' revenue showing a decrease from 83.54% in 2021 to 81.73% in 2022[8]. - The company faces risks from macroeconomic fluctuations, which may lead to short-term volatility in consumer demand[9]. - The company faces risks from intensified industry competition and potential loss of major customers due to high market concentration[125]. - The company acknowledges the uncertainty in industry growth rates, particularly in the baby diaper market, while expecting overall growth in disposable hygiene products[126]. Product Development and Market Trends - The disposable hygiene products industry is experiencing intensified competition, driven by the three-child policy and market changes, necessitating innovation and technological upgrades[6]. - The market for baby diapers has shown signs of stagnation, with a slight decline in market size due to decreasing birth rates, while adult diapers and wipes show clearer growth potential[10]. - The company is actively developing new products in response to market demands, including foam core products and wipes[123]. - The company plans to expand its product line to include life wipes, baby wipes, and medical wipes in addition to sanitary napkin and diaper materials[71]. - The demand for disinfecting wipes and baby wipes is expected to continue growing rapidly, driven by increased consumer awareness of hygiene practices[47]. - The aging population globally, including in China, is leading to a growing demand for adult incontinence products, which is projected to maintain a rapid upward trend[47]. International Expansion and Operations - The company plans to establish more overseas production bases to enhance its international presence, which may introduce management challenges due to differing policies and regulations[15]. - The company has established overseas production bases in Egypt, the USA, and India since the second half of 2017, enhancing its global strategy and reducing logistics costs[52]. - The company aims to enhance its international presence and operational efficiency through the establishment of a holding structure in Singapore for its overseas subsidiaries[59]. - The company is focusing on expanding its overseas market presence, with a strategy to establish production bases in regions like North America and Europe to strengthen international partnerships[124]. Financial Management and Governance - The company has implemented changes in accounting policies as per the new regulations effective from January 1, 2022, impacting the financial reporting[34]. - The company has established a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal standards[135]. - The board of directors consists of 9 members, including 3 independent directors, meeting regulatory requirements for governance structure[134]. - The company maintains independence from its controlling shareholder in operations, finance, and management, ensuring no conflicts of interest or unfair transactions[138]. - The company emphasizes investor relations management, providing multiple channels for communication and ensuring transparency in information disclosure[135]. - The internal audit system is in place to enhance governance and risk control, with an independent audit department reporting to the audit committee[137]. Research and Development - The company holds 27 invention patents, 58 utility model patents, and 46 design patents as of December 31, 2022, showcasing its strong focus on innovation in hygiene product materials[54]. - The company is investing heavily in R&D, with an allocation of 200 million yuan for the development of new technologies in the next fiscal year[186]. - Research and development expenses increased by 20% in 2022, totaling 150 million RMB, focusing on sustainable materials[188]. - The company has a strong focus on research and development, particularly in the field of polymer chemistry, which is critical for its product offerings[145]. Environmental and Social Responsibility - The company is committed to environmental responsibility, actively engaging in tax obligations and promoting employment through public recruitment[180]. - The company has not reported any significant environmental penalties during the reporting period, indicating compliance with environmental regulations[177]. - The company has implemented measures to reduce carbon emissions, although specific details were not disclosed[177]. - The company actively participates in community engagement and sustainable development initiatives[180]. Future Outlook - Future outlook indicates a projected revenue growth of 25% for 2023, driven by new product launches and market expansion strategies[185]. - The company plans to invest 100 million RMB in new technology to enhance production efficiency in 2023[190]. - New product lines are expected to contribute an additional 500 million yuan in revenue in 2023, focusing on eco-friendly materials[185]. - The company is expanding its market presence in Southeast Asia, targeting a 30% market share in the region by 2025[189].

证券代码：300658 证券简称：延江股份 厦门延江新材料股份有限公司 投资者关系活动记录表 编号：2019-12-18 | --- | --- | --- | |-------------------------|----------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------| | | | | | 投资者关系 活动类别 | □媒体采访 □业绩说明会 □ □现场参观 | 特定对象调研 □分析师会议 新闻发布会 □路演活动 | | 参与单位名称 及人员姓名 | □ 其他 四川大决策 王宇 容维投资 刘军 倚天投资 叶飞 上海产业合作中心 杨曦 民商投资 石金华 丰道投资 吴伟 嘉鋆基金 陈朝 前海鑫鼎基金 文波 | | | | 中金万象资本 刘恩举 恒胜资本 赵保保 新华鸡金 谷 ...

厦门延江新材料股份有限公司 2022 年第三季度报告 证券代码：300658 证券简称：延江股份 公告编号：2022-078 厦门延江新材料股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □是 否 1 厦门延江新材料股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 会计政策变更 本报告期 上年同期 本报告期 比上年同 期增减 年初至报 告期末 上年同期 年初至报 告期末比 上年同期 增减 调整前 调整后 调整后 调整前 调整后 调整后 营业收入 （元） 292,398,8 38.60 311,877,8 ...